Neo Ivy Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Neo Ivy Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,723	Closed	-$81K	–	573
2022 Q3	$81K	Buy	1,723 +1,711	+14,258%	+$111K	0.21%	166
2022 Q2	$0	Sell	12 -2,734	-100%	-$200K	﹤0.01%	665
2022 Q1	$222K	Buy	2,746 +1,081	+65%	+$91.4K	0.2%	183
2021 Q4	$171K	Buy	+1,665	New	+$160K	0.25%	154
2020 Q4	–	Sell	-3,675	Closed	-$195K	–	619
2020 Q3	$195K	Buy	+3,675	New	+$219K	0.2%	197
2020 Q2	–	Sell	-4,346	Closed	-$171K	–	636
2020 Q1	$171K	Buy	+4,346	New	+$254K	0.28%	143
2019 Q2	–	Sell	-4,658	Closed	-$241K	–	435
2019 Q1	$241K	Sell	4,658 -1,677	-26%	-$81.3K	0.14%	192
2018 Q4	$249K	Buy	+6,335	New	+$294K	0.2%	196

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Neo Ivy Capital Management's SYNH Position: Q4 2022 in Review

Neo Ivy Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 1,723 shares — an estimated $81K sold.

Neo Ivy Capital Management first reported a position in SYNH in Q4 2018 and held it in 8 quarters. The position peaked at $249K in Q4 2018. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Neo Ivy Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Neo Ivy Capital Management sold 1,723 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $81K.
Neo Ivy Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2018 and held it in 8 quarters.
Neo Ivy Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $249K in Q4 2018.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Neo Ivy Capital Management's 13F filing for Q4 2022, filed 27 Mar 2023.